Medikabazaar Reports 57% Revenue Growth, Targets Rs 3,000 Crore in FY27
Medikabazaar, a B2B healthcare supply chain platform, reported a 57% increase in topline revenue to Rs 592 crore in the first quarter of fiscal year 2026-27. The company aims to reach a Rs 3,000 crore topline by FY 2026-27, reflecting approximately 45% growth over the previous year. This growth is attributed to its integrated healthcare ecosystem, including digital business expansion, medical devices, pharmaceuticals, healthcare exports, strategic accounts, and technology-enabled procurement solutions, according to Managing Director and Group CEO Dinesh Lodha.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (75/100). Lens Score 33/100.
Outlets measured: economictimes, news18. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (75–75/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
news18 broke this story on 27 Jul, 01:17 pm. Other outlets followed.
- 1
